IRIS
SOLINAS, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.802
AS - Asia 2.224
EU - Europa 1.636
SA - Sud America 1.403
AF - Africa 76
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.155
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.726
BR - Brasile 1.246
SG - Singapore 924
CN - Cina 774
UA - Ucraina 698
DE - Germania 246
SE - Svezia 234
HK - Hong Kong 210
IT - Italia 128
FI - Finlandia 110
GB - Regno Unito 84
VN - Vietnam 69
AR - Argentina 61
TR - Turchia 36
BD - Bangladesh 32
RU - Federazione Russa 29
IN - India 28
UZ - Uzbekistan 27
CA - Canada 25
IQ - Iraq 25
VE - Venezuela 23
MX - Messico 22
ZA - Sudafrica 21
EC - Ecuador 20
BE - Belgio 19
MA - Marocco 18
PK - Pakistan 18
CO - Colombia 16
JP - Giappone 14
AU - Australia 11
CL - Cile 11
DZ - Algeria 10
NL - Olanda 10
PL - Polonia 10
ES - Italia 9
FR - Francia 9
PE - Perù 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
ID - Indonesia 8
JM - Giamaica 8
PY - Paraguay 7
AZ - Azerbaigian 6
HN - Honduras 6
NP - Nepal 6
RO - Romania 6
AT - Austria 5
BA - Bosnia-Erzegovina 5
IE - Irlanda 5
KE - Kenya 5
OM - Oman 5
PS - Palestinian Territory 5
UY - Uruguay 5
BG - Bulgaria 4
BO - Bolivia 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
AL - Albania 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
JO - Giordania 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PA - Panama 3
RS - Serbia 3
AO - Angola 2
BH - Bahrain 2
BW - Botswana 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EU - Europa 2
HU - Ungheria 2
KR - Corea 2
LB - Libano 2
LT - Lituania 2
MD - Moldavia 2
NI - Nicaragua 2
PH - Filippine 2
SA - Arabia Saudita 2
SD - Sudan 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CH - Svizzera 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 9.154
Salva come PNG Salva come JPEG
Città #
Dallas 1.054
Chandler 630
Singapore 464
Jacksonville 419
Princeton 214
Hong Kong 210
Nanjing 181
Dearborn 157
Beijing 122
São Paulo 105
Wilmington 105
Ashburn 76
Ann Arbor 67
Nanchang 67
Boardman 64
Shanghai 64
Los Angeles 48
Hebei 40
Shenyang 34
Woodbridge 34
Changsha 31
Tianjin 31
Andover 29
Brasília 29
Rio de Janeiro 29
Santa Clara 29
Belo Horizonte 28
Ho Chi Minh City 27
Jiaxing 26
Sassari 26
Buffalo 23
Tashkent 22
Hangzhou 21
Brussels 18
Porto Alegre 18
Kunming 17
Norwalk 17
Jinan 16
Curitiba 14
Hanoi 14
Tokyo 14
Johannesburg 13
Toronto 13
Uberlândia 13
Campinas 12
Goiânia 12
Amsterdam 10
Baghdad 10
Betim 10
New York 10
Ribeirão Preto 10
Caruaru 9
Caxias do Sul 9
Fortaleza 9
Salvador 9
Santo André 9
Sorocaba 9
Warsaw 9
Guarulhos 8
Marrùbiu 8
Munich 8
São Bernardo do Campo 8
Atlanta 7
Auburn Hills 7
Brooklyn 7
Contagem 7
Council Bluffs 7
Frankfurt am Main 7
Joinville 7
Lahore 7
Medellín 7
Ningbo 7
Quito 7
Recife 7
Santiago 7
São José dos Pinhais 7
Aracaju 6
Baku 6
Casablanca 6
Chennai 6
Dhaka 6
Duque de Caxias 6
Florianópolis 6
Franca 6
João Pessoa 6
Juiz de Fora 6
Lanzhou 6
London 6
Nuremberg 6
Olbia 6
Praia Grande 6
San Francisco 6
Zhengzhou 6
Algiers 5
Ankara 5
Asunción 5
Bauru 5
Belém 5
Boston 5
Bragança Paulista 5
Totale 5.077
Salva come PNG Salva come JPEG
Nome #
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 168
Acute hepatitis with bridging necrosis due to hydralazine intake. Report of a case 148
ARFI (acoustic radiation force impulse imaging) elastography in the liver fibrosis evaluation in HCV correlated chronic liver disease 141
Skin Reaction in Antiviral therapy for Chronic Hepatitis C: A role for Polyethylene Glycol Interferon? 134
CHANGES OF SERUM 2-5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON TREATMENT OF CHRONIC HEPATITIS C 131
Autoimmunity in interferon treated patients with viral chronic liver disease of different etiologies 128
Alteration in thyrotropin (TSH), Prolactin (PRL) and Growth Hormone (GH) secretions in chronic alcoholism and in liver cirrhosis. 123
ASSESSMENT OF VARICEAL PRESSURE WITH AN ENDOSCOPIC BALLOOON: EFFECTS OF PHARMACOLOGICAL THERAPY 120
Alterazioni degli indici di funzionalità tiroidea nelle epatopatie croniche. 116
A randomized controlled trial of interferon alpha-2b as therapy for chronic non-A, non-B hepatitis 113
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients 113
Changes of serum 2-5 olygoadenylate synthetase during interferon treatmnet of chronic hepatitis C 113
A 15 year old girl with fever, jaundice, haemolysis, and sudden clinical deterioration 112
Alpha-fetoprotein and Hepatitis B Virus infection in chronic liver disease 111
Autoantibodies and response to alpha interferon in patients with chronic viral hepatitis 111
The role of pre-coreHBV mutants on the long-term outcome of chronic HBV hepatitis 111
Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas 110
CARRIER DETECTION AND EARLY DIAGNOSIS OF WILSON'S DISEASE BY RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS 109
Patterns of respnse during therapy with interferon and outcome of of retreatment with interferon plus ribavirin 109
Chronic liver disease, alcohol consumption and HBsAg antigen in Italy: a multi-regional control study 109
Alanine amino-transferase, Alpha-fetoprotein, hepatocellular necrosis and regeneration in chronic liver disease 109
T lymphocyte subsets in parenteral and non-parenteral heroin abusers in Britain 107
Aspetti di terapia delle epatiti croniche da virus B e non-A,non-B 106
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 106
Interferon therapy for chronic hepatitis C 104
Antibody to Hepatitis B Surface Antigen in chronic liver disease 104
Lichen planus associated with anti-liver-kidney mocrosome-positive chronic active hepatitis and hyperthyroidism 103
Aspetti della diagnostica delle infezioni croniche da virus dell'epatite B 103
Reazioni cutanee da farmaco: manifestazione eczema-like in corso di terapia antivirale per epatite da virus C 102
Course of patients coinfected with HIV and hepatotropic viruses 99
Changes of serum 2-5- olygoadenilate synthetase during interferon therapy in patients with chronic HCV hepatitis 99
Thyrotropin (TSH) and prolactin (PRL) responses to thyrotropin releasing hormone (TRH) in chronic alcoholism (CA) and in liver cirrhosis (LC) 99
Cognitive dysfunction and hepatitis C virus infection 97
Alanic transferase, Alphafetoprotein, hepatocellular necrosis and regeneration in chronic liver disease. 96
The tumour microenvironment and immune milieu of cholangiocarcinoma 96
The problem of cancer diagnosis in thyroid nodules: a study in an endemic area for goiter in North Sardinia 95
Programmed death ligand 1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer? 95
Porto-hepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitits C virus infection 94
Thymic hormones in the treatment of chronic HBV infection 93
Effect of different doses (1,000,000 AND 3,000,000 units ) od interferon alfa on the ALT levels of nonAnonB patients 92
Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A, non-B hepatitis. A randomized controlled trial 87
Systemic amyloidosis rapidly progressing to liver failure and hepato-renal syndrome. Report of a case 87
Patterns of response during therapy with interferon and outcome of retreatment with interferon plus ribavirin 86
Espressione immunomorfologica e quadri sierologici dell'epatite da virus B 85
Systemic lupus erythematosus in a patient with chronic hepatitis C 85
PRE-CORE MUTANTS AND RESPONSIVENESS TO INTERFERON IN CHRONIC HEPATITIS B 85
The long lasting course of chronic hepatitis C infected patients treated with interferon alfa-2b 84
Impaired thyrotrophin (TSH) response to thyrotrophin releasing hormone (TRH) in hepatic encephalopathy 84
Twenty-four novel mutations in Wilson Disease of predomintaly Italian origin 83
Early diagnosis of Wilsonìs Disease by DNA analysis 83
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) 83
Lichen planus, chronic liver disease and immunologic involvement 82
Impaired thyrotropin (TSH) response to thyrotropin releasing hormone (TRH) in hepatic encephalopathy 82
us-GUIDED DIRECT TRANS-HEPATIC MEASUREMENT OF THE VENOUS PORTAL GRADIENT: A NEW APPROACH TO EVALUATE PORTAL HYPERTENSION 82
Identification of Mycobacterium avium subsp paratuberculosis in biopsy specimens from patients with Crohn\'s disease identified by in situ hybridization 81
High resolution-magic angle spinning (HR-MAS)-NMR based metabolomic fingerprints of early and recurrent hepatocellular carcinoma 81
Identification of Mycobacterium avium subp. paratuberculosis in biopsies from patients with Crohn\'s disease identified by in situ hybridization 80
Pituitary secretion in hepatic encephalopathy 79
Growth hormone (GH) secretion in hepatic encephalopathy 79
Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the study of liver transplantation 78
M. paratuberculosis may cause Crohn’s disease 78
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study 78
Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection 78
HBsAg carrier and liver disease 78
LONG-TERM RESPONSE TO INTERFERON ALFA RE-TREATMENT IN CHRONIC HEPATITIS C 77
Epatite cronica in pazienti con coinfezione multipla HIV-Virus epatotropi 76
Thyrotropin (TSH) and prolactin (PRL) responses to thyrotropin-releasing hormone (TRH) in chronic alcoholism (CA) and in liver cirrhosis (LC) 76
Toxic epidermal necrolysis in a patient affected by mixed essential cryoglobulinemia 73
Occurrence of hepatocellular carcinoma and decompensation in Western patients with cirrhosis type B 72
Receptors for polymerized human serum albumin 72
MOLECULAR PATHOLOGY AND HAPLOTYPE ANALYSIS OF WILSON DISEASE IN MEDITERRANEAN POPULATIONS 72
Enfermedad de Erdheim-Chester: reporte de 2 casos 71
tHE LONG-TERM VARICEAL PRESSURE RESPONSE TO NADOLOL ALONE AND NADOLOL PLUS ISOSORBIDE MONONITRATE 71
Circulating immune complexes during acute viral hepatitis type B: an attempt to detect HBsAg as their antigenic component by means of direct immunofluorescence on Raji cells 71
Immune complexes and complement system in HBsAg positive liver diseases 71
TSH secretion in patients with hepatic encephalopathy 71
Free thyroid hormone concentration in chronic alcoholes with liver steatosis. M. Langer, S. Rassu, P.P. 71
Imaging e valutazione emodinamica nella diagnostica epatologica. Emodinamica epatica invasiva 70
Sex steroids and sex hormone binding globulin in males with chronic alcoholism and liver cirrhosis 70
Interferon alpha therapy in sicilian and sardinan polytransfused thalassemic patients with chronic hepatitis C 69
Livelli sierici delle frazioni C3 e C4 del complemento in corso di epatopatia 68
Hepatitis D Virus infection in parenteral drug abusers 68
Polymerase chain reaction assay for detection of Hepatitis B Virus DNA in the serum of HBsAg/antiHBe positive subjects 68
High resolution-magic angle spinning (HR-MAS) NMR-based metabolomic fingerprinting of early and recurrent hepatocellular carcinoma 67
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon alpha 2b 67
Hepatic hemodynamics and liver function: comparison of a six month course of nadolol and octreotide 67
PROLONGED TREATMENT (2YEARS) WITH DIFFERENT DOSES (3 VS 6 MU) OF INTERFERON ALFA2B FOR CHRONIC HEPATITIS C 66
Free thyroid hormones and chronic liver disease 65
Marcatori del virus dell'epatite B, stato della replicazione virale condizioni cliniche associate 64
Longitudinal study of anti-HBe and DNA polymerase positive patients with chronic liver disease 64
Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis 63
Recurrent Hepatitis Delta Virus infection after liver transplantation 63
Correlazione tra aspetti istologici e valori sierici di alfafetoproteina in epatopatie croniche HBV positive. 63
Characterization of Hepatitis B Virus Core region DNA in circulating Dane particles using direct sequencing of single stranded template generated by asymmetric polymerase chain reaction 63
Il trattamento con levamisolo in corso di epatite cronica attiva 63
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary centres in Europe 62
The predictive value of free thyroid hormones in patients with liver cirrhosis 62
Correlazione tra aspetti istologici e valori serici di AFP in epatopatie croniche HBV positive 60
Growth hormone secretion in chrnic liver disease 60
Late diagnosis of Wilson's Disease: a single center experience over two decades 59
Totale 8.832
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.467
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021515 0 0 0 0 0 56 119 0 145 136 33 26
2021/2022503 93 1 3 2 3 5 37 34 52 14 50 209
2022/20231.182 113 58 15 183 155 206 0 162 214 12 34 30
2023/2024180 66 21 5 10 23 1 0 9 0 0 9 36
2024/20252.595 24 15 175 43 119 57 206 524 950 334 85 63
2025/20262.110 91 907 328 503 230 51 0 0 0 0 0 0
Totale 9.178